CELC צמיחת רווח למניה בשנה הנוכחית celcuity.com
The year-over-year percentage change in EPS for Celcuity Inc. (CELC) demonstrates the impact of cell test patents and strict FDA oversight. The value -36.10 reflects the baseline level of the metric. Growth is based on management's scientific expertise in the field of personalized therapy. Stability is ensured by US localization, which protects intellectual capital from geopolitical risks and trade conflicts.
פילוחים אנליטיים ודוחות נתונים של חברת Celcuity Inc. (CELC)
Seamless express delivery of biomaterials to oncology centers provides Celcuity Inc. (CELC) with a stable operating cycle and revenue predictability. By analyzing the annual volatility of earnings per share, an investor can observe the dynamics of net income per share relative to the previous year, enabling an assessment of business efficiency through the lens of market capitalization and the impact of global liquidity on final returns.
